Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva-Maria Thurner

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
World Journal of Urology|December 18, 2024
Radiotherapy and inflammaging: the influence of prostate cancer radiotherapy on systemic inflammationKatarzyna Paal, Bettina Stranz, Eva-Maria Thurner, et al.
Clinical Chemistry and Laboratory Medicine|April 17, 2026
Mitochondrial DNA copy number in leukocytes predicts long-term survival in prostate cancerTanja Langsenlehner, Katarzyna Paal, Eva-Maria Thurner, et al.
Diagnostics (Basel, Switzerland)|October 7, 2020
The Elevated Pre-Treatment C-Reactive Protein Predicts Poor Prognosis in Patients with Locally Advanced Rectal Cancer Treated with Neo-Adjuvant RadiochemotherapyRichard Partl, Katarzyna Lukasiak, Eva-Maria Thurner, et al.
Scientific Reports|January 21, 2026
Leukocyte telomere attrition following radiotherapy in prostate cancer: a prospective studyTanja Langsenlehner, Katarzyna Paal, Eva- Maria Thurner, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 25, 2011
Association between single nucleotide polymorphisms in the gene for XRCC1 and radiation-induced late toxicity in prostate cancer patientsTanja Langsenlehner, Wilfried Renner, Armin Gerger, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 23, 2011
Impact of VEGF gene polymorphisms and haplotypes on radiation-induced late toxicity in prostate cancer patientsTanja Langsenlehner, Wilfried Renner, Armin Gerger, et al.
Urologic Oncology|March 15, 2015
Evaluation of the platelet-to-lymphocyte ratio as a prognostic indicator in a European cohort of patients with prostate cancer treated with radiotherapyTanja Langsenlehner, Martin Pichler, Eva-Maria Thurner, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 2, 2023
Comprehensive geriatric assessment predicts radiation-induced acute toxicity in prostate cancer patientsKatarzyna Paal, Bettina Stranz, Eva-Maria Thurner, et al.
Scientific Reports|August 6, 2020
Haptoglobin polymorphism and prostate cancer mortalityMelanie Kaiser, Eva-Maria Thurner, Harald Mangge, et al.
World Journal of Urology|January 25, 2015
Validation of the neutrophil-to-lymphocyte ratio as a prognostic factor in a cohort of European prostate cancer patientsTanja Langsenlehner, Eva-Maria Thurner, Sabine Krenn-Pilko, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
World Journal of Urology|December 18, 2024
Radiotherapy and inflammaging: the influence of prostate cancer radiotherapy on systemic inflammationKatarzyna Paal, Bettina Stranz, Eva-Maria Thurner, et al.
Clinical Chemistry and Laboratory Medicine|April 17, 2026
Mitochondrial DNA copy number in leukocytes predicts long-term survival in prostate cancerTanja Langsenlehner, Katarzyna Paal, Eva-Maria Thurner, et al.
Diagnostics (Basel, Switzerland)|October 7, 2020
The Elevated Pre-Treatment C-Reactive Protein Predicts Poor Prognosis in Patients with Locally Advanced Rectal Cancer Treated with Neo-Adjuvant RadiochemotherapyRichard Partl, Katarzyna Lukasiak, Eva-Maria Thurner, et al.
Scientific Reports|January 21, 2026
Leukocyte telomere attrition following radiotherapy in prostate cancer: a prospective studyTanja Langsenlehner, Katarzyna Paal, Eva- Maria Thurner, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 25, 2011
Association between single nucleotide polymorphisms in the gene for XRCC1 and radiation-induced late toxicity in prostate cancer patientsTanja Langsenlehner, Wilfried Renner, Armin Gerger, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|November 23, 2011
Impact of VEGF gene polymorphisms and haplotypes on radiation-induced late toxicity in prostate cancer patientsTanja Langsenlehner, Wilfried Renner, Armin Gerger, et al.
Urologic Oncology|March 15, 2015
Evaluation of the platelet-to-lymphocyte ratio as a prognostic indicator in a European cohort of patients with prostate cancer treated with radiotherapyTanja Langsenlehner, Martin Pichler, Eva-Maria Thurner, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 2, 2023
Comprehensive geriatric assessment predicts radiation-induced acute toxicity in prostate cancer patientsKatarzyna Paal, Bettina Stranz, Eva-Maria Thurner, et al.
Scientific Reports|August 6, 2020
Haptoglobin polymorphism and prostate cancer mortalityMelanie Kaiser, Eva-Maria Thurner, Harald Mangge, et al.
World Journal of Urology|January 25, 2015
Validation of the neutrophil-to-lymphocyte ratio as a prognostic factor in a cohort of European prostate cancer patientsTanja Langsenlehner, Eva-Maria Thurner, Sabine Krenn-Pilko, et al.
Pageof 2